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Abstract
Human adipose tissue is a great source of mesenchymal stem cells. Adipose-derived mesenchymal stem cells 
(AD-MSCs) are easily isolated, able to differentiate into multi-lineage cells and have various clinical application. 
This promising potential will be more valuable for the application of tissue engineering if they can be sequentially 
subcultured without loss of phenotype and multilineage differentiation ability. Thus, in this study we investigated the 
ability of human AD-MSCs to differentiate into osteogenic lineage by performing histological staining and studied the 
osteogenic potential of human AD-MSCs on early (P2, P5), middle (P10) and late passage (P15). Cells were cultured 
in osteogenic medium for 2 weeks and characterized at 1, 4, 7, 10 and 14 days. During sequential subcultivation, AD-
MSCs were able to maintain their osteogenic potential through late passage. AD-MSCs in middle passage exhibited a 
better osteogenic potential than the early and late passages, while the AD-MSCs from P2 are less differentiated than 
middle and late passages. The result that was found in this research should be accounted for when developing stem 
cell-based therapies for clinical application
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Introduction
Bone tissue has the ability to regenerate without leaving scars. 
However, major injury repair of bone tissue caused by trauma, cancer 
or other bone disease remains a challenge for orthopedic surgeons 
[1]. Autologous bone transplantation still has deficiencies such as 
limited autologous tissue available to repair bone damage, donor 
morbidity, possible wound infections, and longer surgery [2]. An 
allogenic transplant given to the patient can be a good alternative, but 
this technique can increase the risk of rejection and disease spread 
[3]. Therefore, it is necessary to develop a new strategy to improve the 
technique of bone regeneration.
New developments in the field of cell therapy have provided a 
new approach in the improvement of bone tissue. Mesenchymal stem 
cells (MSCs) are multipotent stem cells that can renew themselves 
and differentiate into several lines, such as adipogenic, condenset and 
osteogenic precursors [4]. The ability to self-renew and differentiate 
into osteoblast cells makes the MSCs as a good cell source for bone 
tissue engineering. Among the various types of MSCs sources, 
mesenchymal stem cells of adipose tissue origin are multipotent cells 
that are readily available in abundant amounts and can be isolated by 
relatively harmless procedures [5]. Establishment of osteoblast cells 
from MSCs from adipose tissue has tremendous value in developing 
and evaluating methods to bone regeneration process [1-15].
The application of cell biology and tissue culture generally requires 
cell proliferation in vitro to obtain sufficient cell numbers, with most 
studies using stem cells in passages 1 through 5. However, further 
research on the MSC capability of adipose tissue origin in maintaining 
stem cell characteristics and the potential for differentiation in long-
term subcultures. Through the above description, this study aims to 
evaluate the effect of the initial passage (passage ≤ 5, with passages 2 and 
5), middle (passages> 5-10, with passage 10) and old (passage ≥15, 15) 
to the differentiation potential of MSC from adipose tissue to osteoblast 
cells. Osteogenic differentiation in vitro can be done by implanting 
MSC into induction media. The osteogenesis induction media 
component generally consists of dexamethasone (DEX), L-ascorbic 
acid 2 phosphates (ASC) and β-glycerophosphate (β-GP) added to cell 
culture medium for osteogenic differentiation. Each component has 
been shown to support MSC osteogenic differentiation in vitro [6].
Material and Methods
Isolation of MSC of adipose tissue 
Adipose tissue is obtained from a healthy human donor with the 
approval of a medical action at Clinic with the methodology used 
already approved by the applicable code of ethics. Adipose fat tissue was 
isolated enzymatically by collagenase. Incubated at 5% CO2, 37⁰C; if the 
cell reaches 80% confluency, the cell is ready to use for this experiments 
(Figure 1).
MSC culture of adipose tissue 
After the isolation process, the MSC of adipose tissue was grown in 
a growing medium composed of Alpha-Minimum Essential Medium 
(α-MEM) with supplementation of penicillin-streptomycin and serum 
incubated at 37°C and 5% CO2 incubator. The growth medium is 
replaced every 3 days and was calculated (0.05% trypsin-EDTA; Sigma) 
when the cell has reached a confluence. Cells are subcultured every 3-5 
days and propagated to reach passage 3.
Optimization of osteogenic media composition
For optimization of osteogenic media composition, MSC was 
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grown in containers containing growing media supplemented with the 
following osteogenic components.
For the comparison of each osteogenic medium, the cells were 
grown in growing media, i.e. α-MEM + 2.5% serum or α-MEM + 5% 
serum and incubated for several hours before initiating differentiation 
using osteogenic differentiation media [16-30].
Osteogenic differentiation
Osteogenic differentiation was performed using cell passage 
variation and incubation time (Tables 1 and 2). Passages used were 
divided into three groups, namely early passage (passage 2 and 5), 
middle passage (passage 10), and late passage (passage 15). Each 
passage is incubated within 1, 4, 7, 10 and 14 days.
In each incubation time at each passage, there are two dishes 
consisting of control and treatment. The control media and osteogenic 
differentiation media used were selected based on the optimum 
osteogenic composition of the media.
Alizarin red staining
Cells grown in growth medium and osteogenic media for 1, 4, 
7, 10 and 14 days were fixed using formalin 10% for 24 hours. After 
fixation, the cell was then stained using Alizarin red dye and incubated 
for approximately three hours. Visualization of Alizarin red coloring 
results was performed using an inverted microscope.
Result and Discussion 
Optimization of osteogenic media composition
Preliminary research was conducted to determine the most efficient 
osteogenic composition of media in inducing osteogenesis in MSCs of 
adipose tissue. MSC from passage 3 is grown in different osteogenic 
media and incubated for five days. After five days, each culture container 
was characterized using Alizarin red staining (Figure 2).
In Figure 2, it was shown that MSC differentiation results using 
ODM 1 showed significant differences compared with ODM 2 and ODM 
3. In addition, the use of serum with lower concentrations resulted in 
relatively fewer cell counts than MSCs cultured in concentrations of 5% 
serum. Generally, osteogenic differentiation of MSCs in vitro culture 
is performed using ODM 1. However, this osteogenic medium was 
originally used for MSCs differentiation from bone marrow [31-51].
Although MSC from bone marrow and adipose tissue have many 
similar characteristics, their response to induction factors is not 
necessarily identical. Therefore, ODM 1 used in this study is still not 
able to induce osteogenic differentiation well because its component 
concentration has not been optimized for MSC differentiation of 
adipose tissue origin. To determine the optimal osteogenic media, ODM 
2 and ODM 3 used in this study were made with lower dexamethasone 
compositions and higher ascorbic acid compared with ODM 1. 
Based on this research, ODM 2 and ODM 3 may induce osteogenic 
differentiation more good compared to ODM 1.
The influence of osteogenic media on cell count depends on serum 
conditions. In the α-MEM + 2.5% serum condition, the number of cells 
tends to be less than using α-MEM + 5% serum. Appropriate serum 
concentrations are needed to increase cell growth, so the use of serum 
2.5% serum is still not able to support MSC growth optimally.
The characterization results show that ODM 2 using growing 
media α-MEM + 5% serum can produce the most optimal osteoblast 
differentiation compared to other media. This suggests that the 
results of this study are in accordance with research conducted by de 
Girolamo. suggesting that higher use of ascorbic acid concentrations 
and lower dexamethasone may induce osteogenesis in MSCs of 
adipose tissue well. High concentrations of ascorbic acid are reported 
to stimulate the proliferation of MSC from bone marrow and cells 
such as osteoblasts without loss of potential differentiation. Several 
studies have emphasized the importance of ascorbic acid in osteogenic 
differentiation of MSC from bone marrow and cells such as osteoblasts. 
On the other hand, dexamethasone in high concentrations has shown 
inhibition of osteogenic differentiation, although dexamethasone is 
required in low concentrations for effective MSC osteogenic induction 
. Through the above description, the media differentiation used in the 
next step to induce osteogenic differentiation is ODM 2. 
Effect of passage on osteogenic potential of MSC of adipose 
tissue
The MSCs from the isolated adipose tissue are then proliferated to 
certain passages, in passages 2, 10 and 15. The lifespan of the human 
MSC can be categorized into the initial passage (≤5), the middle passage 
(> 5-10) and the old passage (≤ 15), based on the proliferative ability 
and percentage of senescence-associated beta-galactosidase (SA-β-gal, 
biomarker for senescence cells), as has been previously proposed. MSC 
was administered using dexamethasone, 2-phosphate ascorbic acid and 
β-glycerophosphate for 14 days to initiate osteogenic differentiation. 
The osteogenic potential is measured qualitatively by using Alizarin 
red, which is a colorant that gives color to calcium deposition.
The incubation time is an important factor in determining the 
Figure 1: The scheme of forming the MSC stage into osteoblasts and the role of supplements in the induction of osteogenesis. 
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ODM:  Osteogenic Differentiation Media; Serum; Dex, dexamethasone; AsA2-F, 
L-ascorbic acid 2-phosphate; β-GP, beta-glycerophosphate
Table 1: The composition of the media used in the study.
Passage Incubation Time (Day)
Passage 2




Table 2: Optimization of cell passages and incubation time.











Figure 2: MSCs staining results of adipose tissue for osteogenic media optimization. MSCs were cultured in six different osteogenic media for five days and 
stained by using 1% Alizarin red dye.
length of time required to induce MSC differentiation from adipose 
tissue to osteoblasts. In general, osteogenic differentiation is divided 
into three stages: cell proliferation, extracellular matrix maturation 
and matrix mineralization. Cell proliferation can occur on days 1-4, 
followed by maturation of extracellular matrix on days 5-14 and end 
with mineralization of the matrix on days 14-28. Mineralization can 
be detected since the 14th day of induction and increased to 21 days. 
Generally, mineralization begins after osteoblast proliferation and 
formation of extracellular matrix (mostly collagen). Previous studies 
have suggested that mineralization may increase in speed as cell 
proliferation slows due to high cell density.
In this study, since induction of osteogenesis on day 1, most of the 
positive Alizarin red staining results can already be seen. After being 
cultured for one day in osteogenic differentiation media, the cells of the 
three passages have begun to change from the initial morphology, i.e. 
fibroblasts to slightly round. After incubation for 7 days, a number of 
mineralized nodules can be observed and an increase in cell volume in 
passages 10 and 15. A number of studies have shown that cell volume 
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changes are a component of many cellular functions, including epithelial 
transport, metabolism, hormone release, migration, proliferation and 
cell growth and cell death (Figure 3).
In general, cell volume regulation does have an important role in 
cell proliferation and growth, but the role of cellular volume regulation 
in osteoblast lineages remains unclear. Furthermore, at the 14th 
incubation day, the mineralized nodule density becomes more stable 
at passage 10, indicating that the cell has reached a relatively stable 
differentiated condition (Figure 4). During the incubation period 
of 14 days, the cells in passage 2 showed no significant change when 
compared with other passages, while the cells in passage 15 showed 
an increase that could still be seen daily. On the 14th day, cell cultures 
in passage 10 have reached a confluence, so when compared with cell 
cultures in passages 5 and 15, passage 10 images are seen taken with 
smaller magnification. Figure 3 shows the osteogenic differentiation 
picture of MSC passage 10 with 400x magnification.
Based on the results of this study, the MSC of the adipose tissue in 
passage 2 had the fewest number of cells and the differentiated ability to 
be the lowest osteoblast. As explained by Kuznetsov et al. and Satomura 
et al. [26,40] the colonies obtained when planting MSCs in the initial 
passage are heterogeneous colonies in size, morphology and potential 
to differentiate into osteoblasts. In this study, cultures in the early 
Figure 3: MSC cultures in passage 10 that have been incubated in ODM2 for 
14 days. Images taken using 400x magnification.
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Figure 4: Comparison of osteogenic potential of MSC of origin of adipose tissue on the initial, middle and old passages.  All photos with 200x magnification.
passages were also heterogeneous in the potential to differentiate into 
osteoblasts in cultures, so the osteogenic potential of MSCs were not 
equal. In addition, when MSCs were first cultured in vitro, the MSCs 
still retains the characteristics of its stem cells and takes time to adapt to 
new environmental conditions, thus making it difficult to differentiate. 
This can then be the cause of osteogenic potential of MSC in passage 2 
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lower than other passages. On the other hand, in passage 10, the MSCs 
are able to differentiate into osteoblasts with relatively much greater 
number of cells than passages 2 and 15 because the MSCs has been 
adaptable and relatively stable in culture. The potential for osteogenic 
differentiation in passage 15 was sustained although the number of 
osteoblast cells formed is still less than in passage 10. This is probably 
due to MSCs has undergone senescence, resulting in a decrease in 
cell proliferation capacity and may also lead to decreased osteogenic 
potential of MSCs, however it need further study . 
Several studies have shown that the osteogenic activity of MSCs has 
decreased gradually as the passage increases. On the other hand, there 
are other studies suggesting that the osteogenic potential of MSC in 
the old passage can be maintained or even increased. Differences in the 
results of studies related to increased or decreased osteogenic ability of 
MSC with senescence are likely to occur due to differences in culture 
conditions and the lack of optimal in vitro testing to characterize 
osteogenesis completely. Turinetto et al. [43] found that increased cell 
death could result in higher levels of Alizarin red staining, resulting in 
misperceptions about increased osteogenic differentiation.
In the in vitro approach, the number of subcultures that the MSC 
can do without altering its characteristics significantly needs more 
attention. Kim et al. [25] suggests that in vitro (number of passages in 
culture) has a more significant effect on MSC differentiation than in vivo 
(donor physical). In this study, the MSC from adipose tissue managed 
to maintain its differentiation potential to passage 15 and increased the 
differentiation potential from passage 2 to passage 10. The decrease in 
cell number in passage 15 could be caused by cell senescence. However, 
osteogenic differentiation can still occur in both the initial, middle and 
old passages. The results show that the osteogenic potential of MSC 
from adipose tissue does not decrease with age aging in vitro. This is an 
exciting discovery because the ability to repair damaged tissue will in 
reality decline with age.
Summary
Based on the results obtained, it can be concluded that the MSC 
was able to maintain its osteogenic potential until passage 15. The 
result of osteogenic differentiation by using α-MEM culture medium 
supplemented with 5% serum and dexamethasone, ascorbic acid and 
beta-glycerophosphate indicate that passage 10 (middle passage) has 
the best osteogenic potential compared to other passages, while the 
lowest osteogenic potential is seen in MSC passage 2.
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